Stock Information
Royalty Pharma PLC (RPRX)
Ticker Symbol: RPRX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $28,036.45 mil
Piotroski score: 5
PE Ratio: 37.5704
EPS (TTM): 1.3652
Revenue (TTM): $4.27 M
Dividend Yield: 1.8725099601594%
ROE: 11.89%
Latest News
-
Royalty Pharma to present at upcoming investor conferences
Thu, May 7, 2026 4:15 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
Royalty Pharma (NASDAQ:RPRX) Beats Q1 Estimates and Raises Guidance, Fueling Strong Momentum
Wed, May 6, 2026 12:22 PM
-
Royalty Pharma plc (RPRX) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 11:41 AM
-
Royalty Pharma plc Reports Earnings Results for the First Quarter Ended March 31, 2026
Wed, May 6, 2026 10:41 AM
-
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
Wed, May 6, 2026 9:56 AM
-
Transcript : Royalty Pharma plc, Q1 2026 Earnings Call, May 06, 2026
Wed, May 6, 2026 9:35 AM
-
Royalty Pharma plc 2026 Q1 - Results - Earnings Call Presentation
Wed, May 6, 2026 8:35 AM
-
Royalty Pharma : Q1 2026 Financial Results Presentation
Wed, May 6, 2026 7:36 AM
-
Royalty Pharma : Q1 2026 Press Release
Wed, May 6, 2026 7:31 AM
Key Financials
Financial data not available
